1. Development of selective MELK kinase inhibitors for breast cancer treatment. (December 2016) Authors: Wegrzyn, P.; Kowalczyk, P.; Dobrzanska, M.; Knop, M.; Obacz, M.; Gluza, K.; Commandeur, C.; Sabiniarz, A.; Wiklik, K.; Golas, A.; Vaillancourt, F.; Larsen, N.; Wang, J.; Reynolds, D.; Ito, D.; Zou, J.; Aicher, M.; Smith, P.; Zhu, P.; Brzozka, K. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S148 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SEL120–34A, a specific, potent and orally bioavailable inhibitor of CDK8, targets STAT-dependent gene transcription in leukemia and lymphoma models. (December 2016) Authors: Zylkiewicz, E.; Rzymski, T.; Mikula, M.; Dreas, A.; Wiklik, K.; Wrobel, A.; Golas, A.; Dolata, I.; Wojcik, K.; Masiejczyk, M.; Statkiewicz, M.; Kuklinska, U.; Goryca, K.; Grochowsk, A.; Cabaj, A.; Bialas, A.; Mikulski, M.; Windak, R.; Ostrowski, J.; Brzozka, K. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S132 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. VBTC: GPU‐Friendly Variable Block Size Texture Encoding. (27th May 2016) Authors: Krajcevski, P.; Golas, A.; Ramani, K.; Shebanow, M.; Manocha, D. Journal: Computer graphics forum Issue: Volume 35:Number 2(2016) Page Start: 409 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗